Emily Liffick

  • Assistant Professor of Clinical Psychiatry, Psychiatry
  • 139 Citations
  • 5 h-Index
20102019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Emily Liffick is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Psychotic Disorders Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Cognition Medicine & Life Sciences
Placebos Medicine & Life Sciences
Alprazolam Medicine & Life Sciences
Episodic Memory Medicine & Life Sciences
Transcranial Magnetic Stimulation Medicine & Life Sciences
Migraine Disorders Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2010 2019

  • 139 Citations
  • 5 h-Index
  • 11 Article
  • 1 Review article

Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study

Wilbraham, D., Berg, P. H., Tsai, M., Liffick, E., Loo, L. S., Doty, E. G. & Sellers, E., Jan 1 2019, (Accepted/In press) In : Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

Open Access
Alprazolam
Cross-Over Studies
Placebos
Pharmaceutical Preparations
Therapeutics

Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat

Willis, B. A., Andersen, S. W., Ayan-Oshodi, M., James, D. E., Liffick, E., Hillgren, K., Guo, Y. & Monk, S. A., Jan 1 2019, (Accepted/In press) In : Journal of Clinical Pharmacology.

Research output: Contribution to journalArticle

Drug Interactions
Breast Neoplasms
Proteins
Area Under Curve
Rosuvastatin Calcium
2 Citations (Scopus)

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

Krege, J. H., Rizzoli, P. B., Liffick, E., Doty, E. G., Dowsett, S. A., Wang, J. & Buchanan, A. S., Jul 1 2019, In : Cephalalgia. 39, 8, p. 957-966 10 p.

Research output: Contribution to journalArticle

Migraine Disorders
Safety
Placebos
Therapeutics
Hypesthesia
3 Citations (Scopus)

Cognitive effects of bilateral high frequency repetitive transcranial magnetic stimulation in early phase psychosis: a pilot study

Francis, M. M., Hummer, T. A., Vohs, J., Yung, M. G., Visco, A. C., Mehdiyoun, N. F., Kulig, T. C., Um, M., Yang, Z., Motamed, M., Liffick, E., Zhang, Y. & Breier, A., May 31 2018, (Accepted/In press) In : Brain Imaging and Behavior. p. 1-10 10 p.

Research output: Contribution to journalArticle

Transcranial Magnetic Stimulation
Psychotic Disorders
Schizophrenia
Therapeutics
Treatment-Resistant Depressive Disorder
12 Citations (Scopus)

Effects of 12-month, double-blind N-acetyl cysteine on symptoms, cognition and brain morphology in early phase schizophrenia spectrum disorders

Breier, A., Liffick, E., Hummer, T. A., Vohs, J., Yang, Z., Mehdiyoun, N. F., Visco, A. C., Metzler, E., Zhang, Y. & Francis, M. M., Jan 1 2018, (Accepted/In press) In : Schizophrenia Research.

Research output: Contribution to journalArticle

Cognition
Cysteine
Schizophrenia
Brain
Placebos